Effects of Speech Therapy on Voice and Speech in Parkinson's After a 15-day Rehabilitation Course: A Pilot Study

2012 ◽  
Vol 19 (5) ◽  
pp. 273-285 ◽  
Author(s):  
Susanna Simberg ◽  
Johanna Rae ◽  
Emma Kallvik ◽  
Benny Salo ◽  
Kirsti Martikainen
2019 ◽  
Vol 123 ◽  
pp. 156-167 ◽  
Author(s):  
Cassandra Alighieri ◽  
Kim Bettens ◽  
Laura Bruneel ◽  
Charlotte Vandormael ◽  
Duncan Musasizi ◽  
...  

2012 ◽  
Vol 2 (1) ◽  
pp. 321-331 ◽  
Author(s):  
Luísa Farrajota ◽  
Carolina Maruta ◽  
João Maroco ◽  
Isabel Pavão Martins ◽  
Manuela Guerreiro ◽  
...  

2012 ◽  
Vol 68 (4) ◽  
pp. 199-208 ◽  
Author(s):  
Masahiro Abo ◽  
Wataru Kakuda ◽  
Motoi Watanabe ◽  
Azusa Morooka ◽  
Katsuya Kawakami ◽  
...  

2011 ◽  
Vol 3 (2) ◽  
pp. 3-10 ◽  
Author(s):  
Lambert Dechêne ◽  
Michel Tousignant ◽  
Patrick Boissy ◽  
Joël Macoir ◽  
Serge Héroux ◽  
...  

This pilot study explored the feasibility of in-home teletreatment for patients with post-stroke anomia. Three participants over 65 years of age suffering from post-stroke anomia were treated in this pre/post-intervention case study. They received 12 speech therapy teletreatments (two sessions/week for 6 weeks) aimed at improving confrontation naming skills. Half of the failed items from a set of 120 preselected stimuli were trained during treatment (Block A-trained stimuli) while the other half served as controls (Block B-untrained stimuli). Variables measured were: 1) efficacy of treatment (performance on Block-A vs. Block B Stimuli), and 2) participants’ satisfaction with teletreatment (using a French adaptation of the Telemedicine satisfaction questionnaire). All participants showed clinically relevant improvement on confrontation naming of trained items and less improvement for untrained items. The researchers also obtained high satisfaction scores on the questionnaire (above 57/60). This pilot study supports the feasibility of speech therapy teletreatments applied to neurological language disorders.


2020 ◽  
pp. 1-9
Author(s):  
Flávia Viegas ◽  
Danieli Viegas ◽  
Glaucio Serra Guimarães ◽  
Fabio Ritto ◽  
Marcia Simões-Zenari ◽  
...  

Author(s):  
Nico P. Paolillo ◽  
Luca Carrozza ◽  
Maurizio Osio ◽  
Elisabetta Rosa ◽  
Matteo Scalabrin

2019 ◽  
Vol 24 (1) ◽  
Author(s):  
Miguel López-Zamora ◽  
Miriam Cánovas-Cano ◽  
Lourdes Aranda

Abstract: Evaluation of a speech therapy in patients with Alzheimer's disease under cholinergic treatment: A pilot study. The intervention on Alzheimer's disease (AD) has shown that pharmacological treatments with acetylcholinesterase inhibitors are highly beneficial. There is not much evidence if other treatments are effective, because it is difficult to find patients who are not medicated. In the present study a logopedic intervention in patients with AD in the mild phase, with and without pharmacological treatment, was verified. The results show that logopedic intervention slows the deterioration of the disease. The combination of logopedic intervention and pharmacological therapy is confirmed as the therapeutic option that most benefits the patient, while patients who only received one of the treatments show a more pronounced cognitive deterioration. The conclusions indicate that the pharmacological approach is necessary but insufficient, and that a logopedic intervention may be an adequate and effective complement in AD.Keywords: Alzheimer disease; Speech therapy; Acetylcholinesterase inhibitors. Resumen: Al intervenir en pacientes con la enfermedad de Alzheimer (EA) se ha comprobado que los tratamientos farmacológicos con inhibidores de acetilcolinesterasa resultan altamente beneficiosos, pero existen pocas evidencias sobre la efectividad de otros tratamientos debido a que es difícil encontrar pacientes que no estén medicados. En el presente estudio piloto se comprueba la efectividad de una intervención logopédica en enfermos con EA en fase leve, con y sin tratamiento farmacológico. Los resultados muestran que la intervención logopédica frena el deterioro de la enfermedad. La combinación de intervención logopédica y terapia farmacológica es la opción terapéutica que más beneficios reporta al paciente, mientras que los enfermos que sólo recibieron uno de los tratamientos muestran un deterioro cognitivo más pronunciado. Las conclusiones indican que la aproximación farmacológica es necesaria pero insuficiente, y que una intervención logopédica puede ser un complemento adecuado y eficaz de la EA.Palabras clave: Enfermedad de Alzheimer; Intervención logopédica; Inhibidores de acetilcolinesterasa.  


Sign in / Sign up

Export Citation Format

Share Document